药物性牙龈肥大发病机制的研究进展

doi:10.13591/j.cnki.kqyx.2022.06.012

摘要/Abstract

摘要： 药物性牙龈肥大(DIGO)主要由长期服用苯妥英钠、环孢素A、硝苯地平引起,不仅影响牙面的清洁与美观和牙齿正常生理功能,而且可能造成患者心理上的障碍。然而,DIGO发病机制复杂,无法明确,导致治疗较为棘手。许多学者对其进行了多方面的研究,提出许多观点与假设,包括胶原生成与降解失衡机制、炎症等。该文从分子机制与药物具体机制两方面总结了近几年对DIGO发病的研究,并对DIGO未来的研究方向进行探讨,希望能够对DIGO的预防与临床治疗有所帮助。

关键词: 药物性牙龈增生, 胶原, 炎症, 苯妥英钠, 环孢素A, 硝苯地平

Abstract: Drug-induced gingival overgrowth(DIGO)is mainly caused by long-term use of phenytoin sodium, cyclosporine A, and nifedipine . It not only affects the cleanliness and aesthetics of dental surface and the normal physiological function of teeth, but may also cause psychological disorders in patients. However, the pathogenesis of DIGO is complex and remains unclear, making treatment more difficult. Many scholars have studied it from various aspects and put forward many ideas and hypotheses, including the mechanism of collagen production and degradation imbalance, inflammation and so on. This article summarizes research on the pathogenesis of DIGO in recent years from aspects of both molecular mechanism and specific mechanism of drugs, and discusses the future research direction of DIGO, hoping to help the prevention and clinical treatment of DIGO.

Key words: drug-induced gingival overgrowth, collagen, inflammation, phenytoin, cyclosporin A, nifedipine

中图分类号:

R781.4

李佩桐, 王双成, 刘桢, 王骏. 药物性牙龈肥大发病机制的研究进展[J]. 口腔医学, 2022, 42(6): 545-550.

LI Peitong, WANG Shuangcheng, LIU Zhen, WANG Jun. Advances in studies on pathogenesis of drug-induced gingival overgrowth[J]. Stomatology, 2022, 42(6): 545-550.

参考文献

[1] Beaumont J, Chesterman J, Kellett M,et al. Gingival overgrowth: Part 1: Aetiology and clinical diagnosis[J]. Br Dent J, 2017, 222(2):85-91.
[2] Hatahira H, Abe J, Hane Y, et al. Drug-induced gingival hyperplasia: A retrospective study using spontaneous reporting system databases[J]. J Pharm Health Care Sci, 2017, 3: 19.
[3] 陈绍山, 柳志文. 药物性牙龈增生发病机制及治疗的研究进展[J]. 广西医学, 2016, 38(1):98-100.
[4] Nguyen XX, Muhammad L,Nietert PJ, et al. IGFBP-5 promotes fibrosis via increasing its own expression and that of other pro-fibrotic mediators[J]. Front Endocrinol (Lausanne), 2018, 9: 601.
[5] Subramani T,Sakkarai A, Senthilkumar K, et al. Expression of insulin like growth factor binding protein-5 in drug induced human gingival overgrowth[J]. Indian J Med Res, 2007, 125(1):43-48.
[6] Kim KK, Sheppard D, Chapman HA. TGF-β1 signaling and tissue fibrosis[J]. Cold Spring Harb Perspect Biol, 2018, 10(4):a022293.
[7] Hu HH, Chen DQ, Wang YN,et al. New insights into TGF-β/Smad signaling in tissue fibrosis[J]. Chem - Biol Interactions, 2018, 292: 76-83.
[8] Chen JT, Wang CY, Chen MH. Curcumin inhibits TGF-β1-induced connective tissue growth factor expression through the interruption of Smad2 signaling in human gingival fibroblasts[J]. J Formos Med Assoc, 2018, 117(12):1115-1123.
[9] Smith PC, Metz C, de la Peña A, et al. Galectin-8 mediates fibrogenesis induced by cyclosporine in human gingival fibroblasts[J]. J Periodontal Res, 2020, 55(5):724-733.
[10] Lu SL, Huang CF, Li CL,et al. Role of IL-6 and STAT3 signaling in dihydropyridine-induced gingival overgrowth fibroblasts[J]. Oral Dis, 2021, 27(7):1796-1805.
[11] Drobnik J, Pietrucha K, Janczar K, et al. Intra-cerebral implantation of a variety of collagenous scaffolds with nervous embryonic cells[J]. Exp Ther Med, 2019, 18(6):4758-4764.
[12] Sardarian A, Andisheh Tadbir A, Zal F, et al. Altered oxidative status and integrin expression in cyclosporine A-treated oral epithelial cells[J]. Toxicol Mech Methods, 2015, 25(2):98-104.
[13] 蒋春梅, 孙卫斌, 倪杰, 等. 硝苯地平对人牙龈成纤维细胞内钙离子含量的影响[J]. 临床口腔医学杂志, 2005, 21(8):453-455.
[14] Laronha H, Caldeira J. Structure and function of human matrix metalloproteinases[J]. Cells, 2020, 9(5):1076.
[15] Lauritano D, Moreo G, Limongelli L, et al. Drug-induced gingival overgrowth: A pilot study on the effect of diphenylhydantoin and gabapentin on human gingival fibroblasts[J]. Int J Environ Res Public Health, 2020, 17(21):E8229.
[16] Lauritano D, Moreo G, Limongelli L, et al. Drug-induced gingival overgrowth: The effect of cyclosporin A and mycophenolate mophetil on human gingival fibroblasts[J]. Biomedicines, 2020, 8(7):E221.
[17] Ramírez-Rámiz A, Brunet-LLobet L, Lahor-Soler E, et al. On the cellular and molecular mechanisms of drug-induced gingival overgrowth[J]. Open Dent J, 2017, 11: 420-435.
[18] Okanobu A, Matsuda S, Kajiya M, et al. A novel gingival overgrowth mouse model induced by the combination of CsA and ligature-induced inflammation[J]. J Immunol Methods, 2017, 445: 31-36.
[19] Matsuda S,Okanobu A, Hatano S, et al. Relationship between periodontal inflammation and calcium channel blockers induced gingival overgrowth-a cross-sectional study in a Japanese population[J]. Clin Oral Investig, 2019, 23(11):4099-4105.
[20] Rapone B, Ferrara E, Santacroce L, et al. Periodontal microbiological status influences the occurrence of cyclosporine-A and tacrolimus-induced gingival overgrowth[J]. Antibiotics (Basel), 2019, 8(3):E124.
[21] Hu HH, Cao G, Wu XQ,et al. Wnt signaling pathway in aging-related tissue fibrosis and therapies[J]. Ageing Res Rev, 2020, 60: 101063.
[22] Yousefi F, Shabaninejad Z, Vakili S, et al. TGF-β and WNT signaling pathways in cardiac fibrosis: Non-coding RNAs come into focus[J]. Cell Commun Signal, 2020, 18(1):1-16.
[23] 崔硕, 王鹏, 高秀秋. Wnt1、β-catenin在硝苯地平引起的药物性牙龈增生中的表达[J]. 实用口腔医学杂志, 2017, 33(1):78-82.
[24] Tu HP, Chen YT, Fu E,et al. Cyclosporine A enhances gingival β-catenin stability via Wnt signaling[J]. J Periodontol, 2015, 86(3):473-482.
[25] Sridharan S,Nunna P, Jaicob TE, et al. Role of epithelial mesenchymal transition in phenytoin influenced gingival overgrowth in children and young adults. A preliminary clinical and immunohistochemical study[J]. J Clin Pediatr Dent, 2019, 43(5):350-355.
[26] Yang F, Lu J, Yu YC,et al. Epithelial to mesenchymal transition in Cyclosporine A-induced rat gingival overgrowth[J]. Arch Oral Biol, 2017, 81: 48-55.
[27] Lin YH, Yu CC, Lee SS,et al. Elevated Snail expression in human gingival fibroblasts by cyclosporine A as the possible pathogenesis for gingival overgrowth[J]. J Formos Med Assoc, 2015, 114(12):1181-1186.
[28] Tsai CH, Yu CC, Lee SS,et al. Upregulation of Slug expression by cyclosporine A contributes to the pathogenesis of gingival overgrowth[J]. J Formos Med Assoc, 2016, 115(8):602-608.
[29] Alshargabi R, Sano T, Yamashita A, et al. SPOCK₁ is a novel inducer of epithelial to mesenchymal transition in drug-induced gingival overgrowth[J]. Sci Rep, 2020, 10(1):9785.
[30] 詹烨明, 张明珠. 药物性牙龈增生与细胞增殖和凋亡相关性的研究进展[J]. 国际口腔医学杂志, 2018, 45(2):199-203.
[31] Kantarci A, Augustin P, Firatli E, et al. Apoptosis in gingival overgrowth tissues[J]. J Dent Res, 2007, 86(9):888-892.
[32] Lin TC, Yu CC, Liao YW,et al. miR-200a inhibits proliferation rate in drug-induced gingival overgrowth through targeting ZEB2[J]. J Formos Med Assoc, 2020, 119(8):1299-1305.
[33] Han X, Yang RZ, Yang HQ,et al. miR-4651 inhibits cell proliferation of gingival mesenchymal stem cells by inhibiting HMGA2 under nifedipine treatment[J]. Int J Oral Sci, 2020, 12(1):10.
[34] Han X, Yang HQ, Cao YY,et al. The miR-3940-5p inhibits cell proliferation of gingival mesenchymal stem cells[J]. Oral Dis, 2019, 25(5):1363-1373.
[35] Chin YT, Tu HP, Lin CY,et al. Antioxidants protect against gingival overgrowth induced by cyclosporine A[J]. J Periodontal Res, 2021, 56(2):397-407.
[36] Charles N, Ramesh V, Babu KS,et al. Gene polymorphism in amlodipine induced gingival hyperplasia: A case report[J]. J Young Pharm, 2012, 4(4):287-289.
[37] Gagliano N, Costa F, Tartaglia GM,et al. Effects of aging and cyclosporin a on collagen turnover in human gingiva[J]. Open Dent J, 2009, 3: 219-226.
[38] Livada R, Shiloah J. Calcium channel blocker-induced gingival enlargement[J]. J Hum Hypertens, 2014, 28(1):10-14.
[39] Nakayama Y, Inoue E, Kato A,et al. Follicular dendritic cell-secreted protein gene expression is upregulated and spread in nifedipine-induced gingival overgrowth[J]. Odontology, 2020, 108(4):532-544.
[40] 李妍, 孟琛达, 徐全臣. 药物性牙龈肥大的病因研究及治疗进展[J]. 国际口腔医学杂志, 2020, 47(6):693-698.
[41] Nikoloudaki G. Functions of matricellular proteins in dental tissues and their emerging roles in orofacial tissue development, maintenance, and disease[J]. Int J Mol Sci, 2021, 22(12):6626.
[42] 吴陈炫, 姚芳莲, 蔡梁婧, 等. 结缔组织生长因子对支架中培养人牙龈成纤维细胞的作用[J]. 广东医学, 2016, 37(15):2250-2252.
[43] Anand AJ, Gopalakrishnan S, Karthikeyan R,et al. Immunohistochemical analysis of the role connective tissue growth factor in drug-induced gingival overgrowth in response to phenytoin, cyclosporine, and nifedipine[J]. J Int Soc Prev Community Dent, 2018, 8(1):12-20.
[44] 刘倩, 黄萍, 郭淑娟. 骨膜蛋白与牙周病关系的研究进展[J]. 华西口腔医学杂志, 2018, 36(6):681-685.
[45] Kim SS,Nikoloudaki G, Darling M, et al. Phenytoin activates Smad3 phosphorylation and periostin expression in drug-induced gingival enlargement[J]. Histol Histopathol, 2018, 33(12):1287-1298.
[46] Saito K, Mori S, Tanda N,et al. Immunolocalizaiton of c-Myc and bcl-2 proto-oncogene products in gingival hyperplasia induced by nifedipine and phenytoin[J]. J Periodontol, 2000, 71(1):44-49.
[47] Moerke C, Jaco I, Dewitz C, et al. The anticonvulsive Phenhydan^® suppresses extrinsic cell death[J]. Cell Death Differ, 2019, 26(9):1631-1645.
[48] Aboujaoude S, Aoun G, Majzoub Z. Local and systemic effects of cyclosporine A on the severity of gingival overgrowth in post-transplant renal patients[J]. Mater Sociomed, 2021, 33(1):51-55.
[49] Murakami S,Mealey BL, Mariotti A, et al. Dental plaque-induced gingival conditions[J]. J Periodontol, 2018, 89(Suppl 1):S17-S27.
[50] Lin PY,Niimi H, Ohsugi Y, et al. Application of ligature-induced periodontitis in mice to explore the molecular mechanism of periodontal disease[J]. Int J Mol Sci, 2021, 22(16):8900.
[51] 柳惠荣. 环孢素A导致牙龈增生患者治疗前后龈沟液TH1/TH2/TH17细胞因子变化研究[J]. 中国现代医生, 2020, 58(27):5-9.
[52] Ricardo LH, do Prado RF, Carvalho YR,et al. Cyclosporine A-Induced gingival overgrowth and proliferating cell nuclear antigen expression in experimental periodontitis[J]. J Oral Biol Craniofac Res, 2019, 9(1):86-90.
[53] Laird NZ,Malkawi WI, Chakka JL, et al. A proof of concept gene-activated titanium surface for oral implantology applications[J]. J Tissue Eng Regen Med, 2020, 14(4):622-632.
[54] Almahrog AJ, Radwan LR, El-Zehery RR, et al. In vivo association of immunophenotyped macrophages expressing CD163 with PDGF-B in gingival overgrowth-induced by three different categories of medications[J]. J Oral Biol Craniofac Res, 2016, 6(1):10-17.
[55] Bajkovec L, Mrzljak A, Likic R, et al. Drug-induced gingival overgrowth in cardiovascular patients[J]. World J Cardiol, 2021, 13(4):68-75.
[56] Gammons J,Halpage J, Mancarella S. Mapping the proximity interaction network of STIM1 reveals new mechanisms of cytoskeletal regulation[J]. Cells, 2021, 10(10):2701.
[57] He S, Tang S. WNT/β-catenin signaling in the development of liver cancers[J]. Biomed Pharmacother, 2020, 132: 110851.
[58] Yan YF, Zeng JF, Xing LH,et al. Extra- and intra-cellular mechanisms of hepatic stellate cell activation[J]. Biomedicines, 2021, 9(8):1014.
[59] Liang LX, Huang K, Yuan WY,et al. Dysregulations of miR-503-5p and Wnt/β-catenin pathway coordinate in mediating cadmium-induced kidney fibrosis[J]. Ecotoxicol Environ Saf, 2021, 224: 112667.
[60] Xu SS, Ding JF, Shi P,et al. DNMT1-induced miR-152-3p suppression facilitates cardiac fibroblast activation in cardiac fibrosis[J]. Cardiovasc Toxicol, 2021, 21(12):984-999.
[61] Ahangar P, Mills SJ, Smith LE, et al. Human gingival fibroblast secretome accelerates wound healing through anti-inflammatory and pro-angiogenic mechanisms[J]. NPJ Regen Med, 2020, 5(1):24.